PEDIATRICS Vol. 54 No. 2 August 1974, pp. 221
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miller, R. W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Miller, R. W.

VAGINAL CANCER FROM INTRAUTERINE EXPOSURE TO SYNTHETIC ESTROGENS

Robert W. Miller M.D.1

1 Epidemiology Branch, National Cancer Institute-NIH, Bethesda, Maryland

The risk of vaginal cancer among daughters of women who received estrogen during pregnancy has been calculated in the first prospective study reported to date (Lanier, A. P. et al., Mayo Clin. Proc., 48:793, 1973). Among nearly 24,000 children born at the Mayo Clinic obstetrics facilities, 1943 to 1959, no cancers were found among 404 females exposed to synthetic estrogens in the first trimester and traced to 13 to 29 years of age (median, 22 years). From this result it was estimated that the risk of developing vaginal or cervical clear-cell adenocarcinoma was no greater than seven per 1,000 by age 13, and was less than 13 per 1,000 by age 22. No such cancer was found among 400 females exposed in utero during other trimesters than the first. No excess of other cancers or of other diseases was found among the 804 live-born females or 877 males.